Pinnacle Wealth Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Pinnacle Wealth Management Group's ABBV Position: Q3 2026 in Review
Pinnacle Wealth Management Group reduced its AbbVie (ABBV) stake by 4.2% in Q3 2026, selling an estimated $50.5K and leaving 4,522 shares worth $1.18M. The position accounts for 0.54% of the portfolio, ranked #41.
Pinnacle Wealth Management Group first reported a position in ABBV in Q2 2021 and has held it in 22 quarters since. The position peaked at $1.28M in Q1 2022. 3,054 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Pinnacle Wealth Management Group held 4,522 shares of AbbVie worth $1.18M as of Q3 2026.
- Pinnacle Wealth Management Group sold 197 AbbVie shares in Q3 2026, an estimated $50.5K.
- AbbVie made up 0.54% of Pinnacle Wealth Management Group's portfolio in Q3 2026, its #41 holding.
- Pinnacle Wealth Management Group first reported a position in AbbVie in Q2 2021 and has held it in 22 quarters since.
- Pinnacle Wealth Management Group's AbbVie position peaked at $1.28M in Q1 2022.
- 3,054 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Pinnacle Wealth Management Group's 13F filing for Q3 2026, filed 15 Oct 2026.